Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 8 studies | 32% ± 13% | |
| glutamatergic neuron | 4 studies | 37% ± 16% | |
| GABAergic neuron | 4 studies | 29% ± 8% | |
| endothelial cell | 3 studies | 21% ± 3% | |
| adipocyte | 3 studies | 21% ± 4% | |
| interneuron | 3 studies | 34% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 8499.47 | 243 / 245 | 100% | 32.07 | 502 / 502 |
| thymus | 100% | 6310.61 | 651 / 653 | 98% | 9.55 | 590 / 605 |
| pancreas | 100% | 3683.23 | 328 / 328 | 89% | 5.40 | 158 / 178 |
| adrenal gland | 97% | 2270.90 | 249 / 258 | 87% | 4.83 | 199 / 230 |
| breast | 100% | 4292.27 | 459 / 459 | 78% | 5.23 | 873 / 1118 |
| kidney | 97% | 1928.48 | 86 / 89 | 80% | 4.95 | 718 / 901 |
| brain | 94% | 2296.48 | 2492 / 2642 | 81% | 4.11 | 569 / 705 |
| liver | 95% | 2406.77 | 214 / 226 | 61% | 2.53 | 248 / 406 |
| intestine | 99% | 3248.80 | 959 / 966 | 46% | 1.95 | 243 / 527 |
| stomach | 100% | 3988.30 | 358 / 359 | 43% | 1.94 | 122 / 286 |
| lung | 91% | 1754.83 | 528 / 578 | 41% | 2.41 | 476 / 1155 |
| ovary | 100% | 7305.32 | 180 / 180 | 31% | 1.24 | 134 / 430 |
| uterus | 99% | 4822.59 | 169 / 170 | 25% | 1.01 | 114 / 459 |
| bladder | 95% | 3414.43 | 20 / 21 | 28% | 1.08 | 140 / 504 |
| esophagus | 85% | 1825.78 | 1231 / 1445 | 36% | 1.60 | 66 / 183 |
| skin | 79% | 3623.23 | 1425 / 1809 | 33% | 1.31 | 158 / 472 |
| spleen | 100% | 2803.34 | 241 / 241 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2883.08 | 800 / 803 | 0% | 0 | 0 / 0 |
| adipose | 99% | 3402.46 | 1196 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 97% | 2239.45 | 1290 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 5.70 | 28 / 29 |
| heart | 88% | 1478.90 | 758 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 73% | 3.52 | 58 / 80 |
| peripheral blood | 12% | 93.79 | 110 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.24 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0034638 | Biological process | phosphatidylcholine catabolic process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005811 | Cellular component | lipid droplet |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004622 | Molecular function | lysophospholipase activity |
| GO_0102545 | Molecular function | phosphatidyl phospholipase B activity |
| Gene name | PNPLA7 |
| Protein name | Patatin like phospholipase domain containing 7 Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) |
| Synonyms | C9orf111 |
| Description | FUNCTION: Lysophospholipase which preferentially deacylates unsaturated lysophosphatidylcholine (C18:1), generating glycerophosphocholine. Also can deacylate, to a lesser extent, lysophosphatidylethanolamine (C18:1), lysophosphatidyl-L-serine (C18:1) and lysophosphatidic acid (C16:0). . |
| Accessions | ENST00000406427.6 [Q6ZV29-5] F2Z2D4 Q6ZV29 ENST00000491019.2 ENST00000277531.8 [Q6ZV29-1] |
